Role of Human Islet Amyloid Polypeptide in Type 2 Diabetes
Author Information
Author(s): Höppener J. W. M., Jacobs H. M., Wierup N., Sotthewes G., Sprong M., de Vos P., Berger R., Sundler F., Ahrén B.
Primary Institution: University Medical Center Utrecht
Hypothesis
What is the role of human islet amyloid polypeptide (hIAPP) in the development of type 2 diabetes mellitus?
Conclusion
The study found that hIAPP transgenic mice on a high-fat diet developed islet amyloid formation and exhibited severe glucose intolerance, particularly in females.
Supporting Evidence
- Islet amyloid was observed in only 4 of 19 hIAPP transgenic mice after a high-fat diet.
- Higher plasma IAPP levels were found in hIAPP mice compared to nontransgenic mice.
- Female hIAPP mice showed severe glucose intolerance compared to male hIAPP mice.
Takeaway
Scientists created special mice that produce a protein linked to diabetes to see how it affects their blood sugar levels, especially when they eat a lot of fat.
Methodology
Transgenic mice were fed a high-fat diet for 14 months, and their glucose tolerance and islet amyloid formation were assessed.
Potential Biases
Potential bias in the interpretation of results due to the genetic background of the mice.
Limitations
The study's findings may not fully represent human diabetes due to the use of animal models.
Participant Demographics
Transgenic mice, including both male and female subjects.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website